在工程和RNA干扰纳米平台的模拟中,用于治疗骨质疏松症和促进骨愈合
Aylar Imanpour1, Hanieh Kolahi Azar1,2, Dorna Makarem3
1Regenerative Medicine Group (REMED), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Scientific reports
|October 24, 2023
概括
这项研究探讨了用于骨质疏松症治疗的RNA干扰 (RNAi),确定稳定的纳米载体,以有针对性地传递微RNA (miRNA) 和小干扰RNA (siRNA),以促进骨修复.
科学领域:
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
- 纳米技术纳米技术
背景情况:
- 骨质疏松症是一种普遍的骨疾病,其特点是骨矿物质密度低,骨质差,往往导致骨折.
- 目前对骨质疏松症的治疗方法有限,这凸显了对新型治疗策略的需求.
- 使用microRNAs (miRNAs) 和小干扰RNAs (siRNAs) 的RNA干扰 (RNAi) 显示出通过向特定基因来治疗骨质疏松症的前景.
研究的目的:
- 确定用于骨质疏松症治疗和骨修复的新型miRNA和siRNA对抗剂.
- 评估适合的纳米载体,以有效地提供RNAi疗法.
- 研究系统生物学和分子动力学模拟在骨质疏松症药物发现中的潜力.
主要方法:
- 用基因本体学分析和系统生物学方法来确定潜在的治疗点.
- 用分子动力学 (MD) 模拟来评估不同纳米载体内的RNAi分子的稳定性.
- 测试了三种纳米载体:聚乙烯糖醇 (PEG),聚乙烯胺 (PEI) 和PEG-PEI共聚物.
主要成果:
- MD模拟表明,PEG-PEI共聚物是has-mIR-146a-5p (总能量=-372.84 kJ/mol) 的高度稳定的纳米载体.
- PEI被确定为一个合适的输送载体 has-mIR-7155.5.
- 该研究确定了特定的RNAi分子和优化的纳米载体配方,用于骨质疏松症治疗.
结论:
- 开发的RNAi疗法,通过生物响应纳米载体传递,显示出加速骨修复和治疗骨质疏松症的潜力.
- 系统生物学和MD模拟是设计有效的基于RNAi的疗法的宝贵工具.
- 这项研究为新的基于纳米载体的骨质疏松症治疗铺平了道路.
更多相关视频
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.7K
11:53Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
7.4K
相关概念视频
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:23RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K